Top
18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
DOI: 10.1186/s40644-020-00313-2, Volume: 20, Pages: 0-0
Article Type: research-article,
Article History
received:
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1186/s40644-020-00313-2&title=<sup>18</sup>F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma&author=&keyword=[{keywordId=3, uniqueName=melanoma, name=Melanoma, contentId=12974}, {keywordId=2077, uniqueName=biomarker, name=Biomarker, contentId=12974}, {keywordId=15712, uniqueName=immune-checkpoint-blockade, name=Immune checkpoint blockade, contentId=12974}, {keywordId=15713, uniqueName=positron-emission-tomography, name=Positron emission tomography, contentId=12974}, {keywordId=15714, uniqueName=spleen-to-liver-ratio, last=true, name=Spleen to liver ratio, contentId=12974}],[{keywordId=3, uniqueName=melanoma, name=Melanoma, contentId=12974}, {keywordId=2077, uniqueName=biomarker, name=Biomarker, contentId=12974}, {keywordId=15712, uniqueName=immune-checkpoint-blockade, name=Immune checkpoint blockade, contentId=12974}, {keywordId=15713, uniqueName=positron-emission-tomography, name=Positron emission tomography, contentId=12974}, {keywordId=15714, uniqueName=spleen-to-liver-ratio, last=true, name=Spleen to liver ratio, contentId=12974}],[{keywordId=3, uniqueName=melanoma, name=Melanoma, contentId=12974}, {keywordId=2077, uniqueName=biomarker, name=Biomarker, contentId=12974}, {keywordId=15712, uniqueName=immune-checkpoint-blockade, name=Immune checkpoint blockade, contentId=12974}, {keywordId=15713, uniqueName=positron-emission-tomography, name=Positron emission tomography, contentId=12974}, {keywordId=15714, uniqueName=spleen-to-liver-ratio, last=true, name=Spleen to liver ratio, contentId=12974}],[{keywordId=3, uniqueName=melanoma, name=Melanoma, contentId=12974}, {keywordId=2077, uniqueName=biomarker, name=Biomarker, contentId=12974}, {keywordId=15712, uniqueName=immune-checkpoint-blockade, name=Immune checkpoint blockade, contentId=12974}, {keywordId=15713, uniqueName=positron-emission-tomography, name=Positron emission tomography, contentId=12974}, {keywordId=15714, uniqueName=spleen-to-liver-ratio, last=true, name=Spleen to liver ratio, contentId=12974}],[{keywordId=3, uniqueName=melanoma, name=Melanoma, contentId=12974}, {keywordId=2077, uniqueName=biomarker, name=Biomarker, contentId=12974}, {keywordId=15712, uniqueName=immune-checkpoint-blockade, name=Immune checkpoint blockade, contentId=12974}, {keywordId=15713, uniqueName=positron-emission-tomography, name=Positron emission tomography, contentId=12974}, {keywordId=15714, uniqueName=spleen-to-liver-ratio, last=true, name=Spleen to liver ratio, contentId=12974}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova